Loading…
Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus
Aims To understand wound healing after drug-eluting stents (DES) placement in humans, we studied the histology of in-stent restenosis (ISR) tissue obtained by atherectomy from bare metal stents (BMS) and DES in comparison with de novo atherosclerosis. Methods and results The tissue was retrieved fro...
Saved in:
Published in: | European heart journal 2007-04, Vol.28 (8), p.974-979 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-bce7f08459ba91e1bdfdfc36d461e0bce5c2087141686b304632bc9e9a4700963 |
---|---|
cites | |
container_end_page | 979 |
container_issue | 8 |
container_start_page | 974 |
container_title | European heart journal |
container_volume | 28 |
creator | van Beusekom, Heleen M.M. Saia, Francesco Zindler, Jaap D. Lemos, Pedro A. Hoor, Stijn L. Swager-ten van Leeuwen, Maarten A.H. de Feijter, Pim J. Serruys, Patrick W. van der Giessen, Willem J. |
description | Aims
To understand wound healing after drug-eluting stents (DES) placement in humans, we studied the histology of in-stent restenosis (ISR) tissue obtained by atherectomy from bare metal stents (BMS) and DES in comparison with de novo atherosclerosis.
Methods and results
The tissue was retrieved from ISR in ten sirolimus-eluting stents (SES) and nine paclitaxel-eluting stents (PES), six BMS, and nine stenotic de novo atherosclerotic lesions and processed for histology and immunocytochemistry. Patients with ISR in PES showed a significantly higher incidence of unstable angina upon presentation for re-intervention (P = 0.046). De novo tissue tended to be more collagen rich, whereas ISR tissue tended to be more proteoglycan rich. In all groups, cell content consisted almost exclusively of smooth muscle cells. Histology showed that fibrinoid in ISR tissue was present only in DES (P = 0.004), as late as 2 years following DES placement, indicating a persistent incomplete healing response. The amount of fibrinoid, given as a percentage of total tissue in each atherectomy specimen, was greater in PES than in SES (17 vs. 5%, P = 0.026).
Conclusion
ISR in DES shows incomplete neointimal healing as late as 2 years after implantation. Patients with ISR in PES presented with more unstable angina and showed more pronounced signs of delayed healing than SES. |
doi_str_mv | 10.1093/eurheartj/ehm064 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70403644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehm064</oup_id><sourcerecordid>1261029531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-bce7f08459ba91e1bdfdfc36d461e0bce5c2087141686b304632bc9e9a4700963</originalsourceid><addsrcrecordid>eNqF0M9LwzAUB_AgipvTuycpgl6k-tKmaeNN5k8YeFDBW0nTV9eRNjNp0P33RjYUvHjK4X3ej3wJOaRwTkGkF-jtHKUdFhc474CzLTKmWZLEgrNsm4yBiizmvHgdkT3nFgBQcMp3yYjmLGVFkYzJ07X1bzFqP7T9W-QG7AcXubn5iGrUcoV1FBboULuMllLpdpCfqKPOWIyW1vTG9yqYYS77yLXW6Lbzbp_sNFI7PNi8E_Jye_M8vY9nj3cP06tZrFIBQ1wpzBsoWCYqKSjSqm7qRqW8ZpwihGqmEihyyigveJUC42lSKYFCshxA8HRCTtdzwyXvHt1Qdq1TqLXs0XhX5sAg5YwFePwHLoy3fbitTGiWARdcBARrpKxxzmJTLm3bSbsqKZTfaZc_aZfrtEPL0Waurzqsfxs28QZwsgHSKakbK3vVul9X5Mn3_4M7Wzvjl_-v_QIQGJsc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215506969</pqid></control><display><type>article</type><title>Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus</title><source>Oxford Journals Online</source><creator>van Beusekom, Heleen M.M. ; Saia, Francesco ; Zindler, Jaap D. ; Lemos, Pedro A. ; Hoor, Stijn L. Swager-ten ; van Leeuwen, Maarten A.H. ; de Feijter, Pim J. ; Serruys, Patrick W. ; van der Giessen, Willem J.</creator><creatorcontrib>van Beusekom, Heleen M.M. ; Saia, Francesco ; Zindler, Jaap D. ; Lemos, Pedro A. ; Hoor, Stijn L. Swager-ten ; van Leeuwen, Maarten A.H. ; de Feijter, Pim J. ; Serruys, Patrick W. ; van der Giessen, Willem J.</creatorcontrib><description>Aims
To understand wound healing after drug-eluting stents (DES) placement in humans, we studied the histology of in-stent restenosis (ISR) tissue obtained by atherectomy from bare metal stents (BMS) and DES in comparison with de novo atherosclerosis.
Methods and results
The tissue was retrieved from ISR in ten sirolimus-eluting stents (SES) and nine paclitaxel-eluting stents (PES), six BMS, and nine stenotic de novo atherosclerotic lesions and processed for histology and immunocytochemistry. Patients with ISR in PES showed a significantly higher incidence of unstable angina upon presentation for re-intervention (P = 0.046). De novo tissue tended to be more collagen rich, whereas ISR tissue tended to be more proteoglycan rich. In all groups, cell content consisted almost exclusively of smooth muscle cells. Histology showed that fibrinoid in ISR tissue was present only in DES (P = 0.004), as late as 2 years following DES placement, indicating a persistent incomplete healing response. The amount of fibrinoid, given as a percentage of total tissue in each atherectomy specimen, was greater in PES than in SES (17 vs. 5%, P = 0.026).
Conclusion
ISR in DES shows incomplete neointimal healing as late as 2 years after implantation. Patients with ISR in PES presented with more unstable angina and showed more pronounced signs of delayed healing than SES.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehm064</identifier><identifier>PMID: 17434882</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Aged ; Aged, 80 and over ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cardiology. Vascular system ; Coronary Restenosis - physiopathology ; Coronary Restenosis - prevention & control ; Drug Implants ; Female ; Humans ; Immunosuppressive Agents - administration & dosage ; Male ; Medical sciences ; Middle Aged ; Paclitaxel - administration & dosage ; Pharmacology. Drug treatments ; Sirolimus - administration & dosage ; Stents ; Tubulin Modulators - administration & dosage ; Wound Healing - drug effects</subject><ispartof>European heart journal, 2007-04, Vol.28 (8), p.974-979</ispartof><rights>The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2007</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Apr 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-bce7f08459ba91e1bdfdfc36d461e0bce5c2087141686b304632bc9e9a4700963</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18728459$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17434882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Beusekom, Heleen M.M.</creatorcontrib><creatorcontrib>Saia, Francesco</creatorcontrib><creatorcontrib>Zindler, Jaap D.</creatorcontrib><creatorcontrib>Lemos, Pedro A.</creatorcontrib><creatorcontrib>Hoor, Stijn L. Swager-ten</creatorcontrib><creatorcontrib>van Leeuwen, Maarten A.H.</creatorcontrib><creatorcontrib>de Feijter, Pim J.</creatorcontrib><creatorcontrib>Serruys, Patrick W.</creatorcontrib><creatorcontrib>van der Giessen, Willem J.</creatorcontrib><title>Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Aims
To understand wound healing after drug-eluting stents (DES) placement in humans, we studied the histology of in-stent restenosis (ISR) tissue obtained by atherectomy from bare metal stents (BMS) and DES in comparison with de novo atherosclerosis.
Methods and results
The tissue was retrieved from ISR in ten sirolimus-eluting stents (SES) and nine paclitaxel-eluting stents (PES), six BMS, and nine stenotic de novo atherosclerotic lesions and processed for histology and immunocytochemistry. Patients with ISR in PES showed a significantly higher incidence of unstable angina upon presentation for re-intervention (P = 0.046). De novo tissue tended to be more collagen rich, whereas ISR tissue tended to be more proteoglycan rich. In all groups, cell content consisted almost exclusively of smooth muscle cells. Histology showed that fibrinoid in ISR tissue was present only in DES (P = 0.004), as late as 2 years following DES placement, indicating a persistent incomplete healing response. The amount of fibrinoid, given as a percentage of total tissue in each atherectomy specimen, was greater in PES than in SES (17 vs. 5%, P = 0.026).
Conclusion
ISR in DES shows incomplete neointimal healing as late as 2 years after implantation. Patients with ISR in PES presented with more unstable angina and showed more pronounced signs of delayed healing than SES.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Coronary Restenosis - physiopathology</subject><subject>Coronary Restenosis - prevention & control</subject><subject>Drug Implants</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Paclitaxel - administration & dosage</subject><subject>Pharmacology. Drug treatments</subject><subject>Sirolimus - administration & dosage</subject><subject>Stents</subject><subject>Tubulin Modulators - administration & dosage</subject><subject>Wound Healing - drug effects</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqF0M9LwzAUB_AgipvTuycpgl6k-tKmaeNN5k8YeFDBW0nTV9eRNjNp0P33RjYUvHjK4X3ej3wJOaRwTkGkF-jtHKUdFhc474CzLTKmWZLEgrNsm4yBiizmvHgdkT3nFgBQcMp3yYjmLGVFkYzJ07X1bzFqP7T9W-QG7AcXubn5iGrUcoV1FBboULuMllLpdpCfqKPOWIyW1vTG9yqYYS77yLXW6Lbzbp_sNFI7PNi8E_Jye_M8vY9nj3cP06tZrFIBQ1wpzBsoWCYqKSjSqm7qRqW8ZpwihGqmEihyyigveJUC42lSKYFCshxA8HRCTtdzwyXvHt1Qdq1TqLXs0XhX5sAg5YwFePwHLoy3fbitTGiWARdcBARrpKxxzmJTLm3bSbsqKZTfaZc_aZfrtEPL0Waurzqsfxs28QZwsgHSKakbK3vVul9X5Mn3_4M7Wzvjl_-v_QIQGJsc</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>van Beusekom, Heleen M.M.</creator><creator>Saia, Francesco</creator><creator>Zindler, Jaap D.</creator><creator>Lemos, Pedro A.</creator><creator>Hoor, Stijn L. Swager-ten</creator><creator>van Leeuwen, Maarten A.H.</creator><creator>de Feijter, Pim J.</creator><creator>Serruys, Patrick W.</creator><creator>van der Giessen, Willem J.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus</title><author>van Beusekom, Heleen M.M. ; Saia, Francesco ; Zindler, Jaap D. ; Lemos, Pedro A. ; Hoor, Stijn L. Swager-ten ; van Leeuwen, Maarten A.H. ; de Feijter, Pim J. ; Serruys, Patrick W. ; van der Giessen, Willem J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-bce7f08459ba91e1bdfdfc36d461e0bce5c2087141686b304632bc9e9a4700963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Coronary Restenosis - physiopathology</topic><topic>Coronary Restenosis - prevention & control</topic><topic>Drug Implants</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Paclitaxel - administration & dosage</topic><topic>Pharmacology. Drug treatments</topic><topic>Sirolimus - administration & dosage</topic><topic>Stents</topic><topic>Tubulin Modulators - administration & dosage</topic><topic>Wound Healing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Beusekom, Heleen M.M.</creatorcontrib><creatorcontrib>Saia, Francesco</creatorcontrib><creatorcontrib>Zindler, Jaap D.</creatorcontrib><creatorcontrib>Lemos, Pedro A.</creatorcontrib><creatorcontrib>Hoor, Stijn L. Swager-ten</creatorcontrib><creatorcontrib>van Leeuwen, Maarten A.H.</creatorcontrib><creatorcontrib>de Feijter, Pim J.</creatorcontrib><creatorcontrib>Serruys, Patrick W.</creatorcontrib><creatorcontrib>van der Giessen, Willem J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Beusekom, Heleen M.M.</au><au>Saia, Francesco</au><au>Zindler, Jaap D.</au><au>Lemos, Pedro A.</au><au>Hoor, Stijn L. Swager-ten</au><au>van Leeuwen, Maarten A.H.</au><au>de Feijter, Pim J.</au><au>Serruys, Patrick W.</au><au>van der Giessen, Willem J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>28</volume><issue>8</issue><spage>974</spage><epage>979</epage><pages>974-979</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Aims
To understand wound healing after drug-eluting stents (DES) placement in humans, we studied the histology of in-stent restenosis (ISR) tissue obtained by atherectomy from bare metal stents (BMS) and DES in comparison with de novo atherosclerosis.
Methods and results
The tissue was retrieved from ISR in ten sirolimus-eluting stents (SES) and nine paclitaxel-eluting stents (PES), six BMS, and nine stenotic de novo atherosclerotic lesions and processed for histology and immunocytochemistry. Patients with ISR in PES showed a significantly higher incidence of unstable angina upon presentation for re-intervention (P = 0.046). De novo tissue tended to be more collagen rich, whereas ISR tissue tended to be more proteoglycan rich. In all groups, cell content consisted almost exclusively of smooth muscle cells. Histology showed that fibrinoid in ISR tissue was present only in DES (P = 0.004), as late as 2 years following DES placement, indicating a persistent incomplete healing response. The amount of fibrinoid, given as a percentage of total tissue in each atherectomy specimen, was greater in PES than in SES (17 vs. 5%, P = 0.026).
Conclusion
ISR in DES shows incomplete neointimal healing as late as 2 years after implantation. Patients with ISR in PES presented with more unstable angina and showed more pronounced signs of delayed healing than SES.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>17434882</pmid><doi>10.1093/eurheartj/ehm064</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-668X |
ispartof | European heart journal, 2007-04, Vol.28 (8), p.974-979 |
issn | 0195-668X 1522-9645 |
language | eng |
recordid | cdi_proquest_miscellaneous_70403644 |
source | Oxford Journals Online |
subjects | Aged Aged, 80 and over Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cardiology. Vascular system Coronary Restenosis - physiopathology Coronary Restenosis - prevention & control Drug Implants Female Humans Immunosuppressive Agents - administration & dosage Male Medical sciences Middle Aged Paclitaxel - administration & dosage Pharmacology. Drug treatments Sirolimus - administration & dosage Stents Tubulin Modulators - administration & dosage Wound Healing - drug effects |
title | Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A24%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-eluting%20stents%20show%20delayed%20healing:%20paclitaxel%20more%20pronounced%20than%20sirolimus&rft.jtitle=European%20heart%20journal&rft.au=van%20Beusekom,%20Heleen%20M.M.&rft.date=2007-04-01&rft.volume=28&rft.issue=8&rft.spage=974&rft.epage=979&rft.pages=974-979&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehm064&rft_dat=%3Cproquest_cross%3E1261029531%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-bce7f08459ba91e1bdfdfc36d461e0bce5c2087141686b304632bc9e9a4700963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=215506969&rft_id=info:pmid/17434882&rft_oup_id=10.1093/eurheartj/ehm064&rfr_iscdi=true |